20n

San Francisco, United States Founded: 2013 • Age: 13 yrs
Computational tools are developed to engineer microbes for synthetic biology.

About 20n

20n is a company based in San Francisco (United States) founded in 2013.. 20n has raised $2.22 million across 2 funding rounds from investors including Khosla Ventures, Y Combinator and Blumberg Capital. 20n operates in a competitive market with competitors including Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others.

  • Headquarter San Francisco, United States
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.22 M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.1 M (USD), Seed

    May 01, 2015

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of 20n

20n has successfully raised a total of $2.22M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2.1 million completed in May 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $2.1M
  • First Round

    (01 Dec 2014)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2015 Amount Seed - 20n Valuation

investors

Dec, 2014 Amount Seed - 20n Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in 20n

20n has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, Y Combinator and Blumberg Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage startups are accelerated via funding and educational programs.
Founded Year Domain Location
Early-stage startups are funded by this venture capital firm.
Founded Year Domain Location
Venture capital firm investing in early and growth stage technology companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by 20n

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - 20n

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

20N Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of 20n

20n operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Pivot Bio, Ginkgo Bioworks and Syngenta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of renewable products for industrial solutions
domain founded_year HQ Location
Speech recognition solutions are provided by Inscripta for healthcare professionals.
domain founded_year HQ Location
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
domain founded_year HQ Location
Gene editing-based cultured ingredients are provided for agriculture.
domain founded_year HQ Location
Crop protection solutions and hybrid seeds are provided for farming.
domain founded_year HQ Location
Provider of integrated suite for advanced genetic design and manufacturing
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on 20N

Frequently Asked Questions about 20n

When was 20n founded?

20n was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is 20n located?

20n is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Is 20n a funded company?

20n is a funded company, having raised a total of $2.22M across 2 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Dec 01, 2014.

What does 20n do?

Founded in 2013 in San Francisco, United States, the company operates in the synthetic biology sector. Microbes such as E. coli and yeast are engineered with a mushroom-derived gene and over-expressed native genes PabABC and nhoA to convert sugar into acetaminophen. DNA blueprints depicting enzymatic pathways are provided. Data mining, machine learning, program synthesis, and natural language processing are combined to advance biotechnology applications.

Who are the top competitors of 20n?

20n's top competitors include Syngenta, Synthego and Antheia.

Who are 20n's investors?

20n has 4 investors. Key investors include Khosla Ventures, Y Combinator, Blumberg Capital, and Great Oaks Venture Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available